Cargando…
Immunoglobulin abnormalities are frequent in patients with lupus nephritis
BACKGROUND: Hypogammaglobulinemia is a complication of B-cell targeting therapies (BCTT), used in vasculitis, rheumatoid arthritis and systemic lupus erythematosus (SLE). Since autoimmune diseases are associated with underlying and induced immune abnormalities, several societies recommend assessing...
Autores principales: | Cuadrado, M. J., Calatayud, I., Urquizu-Padilla, M., Wijetilleka, S., Kiani-Alikhan, S., Karim, M. Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702722/ https://www.ncbi.nlm.nih.gov/pubmed/31453435 http://dx.doi.org/10.1186/s41927-019-0079-2 |
Ejemplares similares
-
Intravenous Immunoglobulin in the Management of Lupus Nephritis
por: Wenderfer, Scott E., et al.
Publicado: (2012) -
Lupus Nephritis in an Adolescent Girl With Hyper-Immunoglobulin E
por: Alahmadi, Ghadeer G, et al.
Publicado: (2023) -
Mesangial Cell-Binding Activity of Serum Immunoglobulin G in Patients with Lupus Nephritis
por: Yap, Desmond Y. H., et al.
Publicado: (2014) -
Experience with abatacept in refractory lupus nephritis
por: Calatayud, Emma, et al.
Publicado: (2023) -
Diagnostic Utility of Galactose-Deficient Immunoglobulin A1 Immunostaining in the Differentiation of Lupus Nephritis and Immunoglobulin A Nephropathy
por: Bu, Lihong, et al.
Publicado: (2021)